Public Health, Health Services Research and HTA

HTADS Continuing Education Program

What is the Continuing Education Program on Health Technology Assessment & Decision Sciences (HTADS)?

Health Technology Assessment (HTA) has been defined by the International Network of Agencies for HTA (INAHTA) as "a multidisciplinary field of policy analysis, studying the medical, economic, social, and ethical implications of development, diffusion and use of health technologies (e.g., drugs, devices, surgical procedures, prevention techniques)".
In conducting HTA, the discipline of decision sciences has become increasingly relevant.

Decision Sciences (DS) is the application of explicit and quantitative methods to analyze decisions under conditions of uncertainty (e.g., meta-analysis, decision-analytic modeling, cost-effectiveness analysis).

In recent years, HTA and DS have become very important to health care policymakers.
In order to keep pace with these developments, the UMIT-HTADS Program was designed to provide excellent quality education and comprehensive training in the key issues of HTA and DS for anyone involved in the health sector.

Doctoral Program  / HTADS Certificate Courses

 

Doctoral Program Health Technology Assessment

 

Certificate Courses

                          
M1: 5-Day Certified University Course
Autumn School in Clinical Epidemiology

13 - 17 SEP 2021

M2: 4-Day Certified University Course
Introduction to Health Technology Assessment

2022 - tbd.

M3: 3-Day Certified University Course
Modeling Approaches for HTA: A Practical Hands-on Workshop

08 - 10 SEP 2021

M4: 5-Day Certified University Course
Causal Inference for Assessing Effectiveness in Real World Data and Clinical Trials: A Practical Hands-on Workshop

31 JAN - 04 FEB 2022

M5: 3-Day Certified University Course
Scientific Reporting and Writing
15 - 17 NOV 2021
M7: 3-Day Certified University Course
Advanced Systematic Reviews and Meta-Analysis
ONLINE
07 - 09 April 2022
Certificate Courses in Statistics and Epidemiology 2020/2021

In case of international travel restrictions, the courses will be organized as synchronous online courses.

 

Comments of participants of our previous courses:

'The 4-day course helped me to better understand the framework for HTA, and put the bits and pieces together. The course was dynamic, and assuming that people have some basic previous knowledge, it provides with the maximum effect. We were wondering that the participants were still smiling after 12 hours of work - quite uncommon for any training course.'

Mikk Jurisson, MD
Merck Sharp & Dome, Managing Director Baltics